Presbia PLC announced that Casey Lind has been appointed as Chief Operating Officer, effective February 12, 2018. As Chief Operating Officer, Ms. Lind is responsible for the company’s manufacturing, engineering, quality and IT departments. Ms. Lind brings over 30 years of experience, including 29 years at Alcon where she was in senior leadership positions across manufacturing, global supply chain, and research & development. In addition, the company announced that Dr. Magda Michna, PhD will become Chief Clinical Officer, also effective February 12, 2018. Dr. Michna will increase her responsibility overseeing clinical affairs to also include the company’s medical affairs and regulatory functions. Dr. Michna joined the company in February 2017 as VP of Clinical Affairs, bringing more than 12 years of experience in ophthalmic clinical research and development.